253 related articles for article (PubMed ID: 2945704)
1. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
Kuhlman DS; Callen JP
Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
[TBL] [Abstract][Full Text] [Related]
2. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
[TBL] [Abstract][Full Text] [Related]
3. A comparison of Cleocin T 1 percent solution and Cleocin T 1 percent lotion in the treatment of acne vulgaris.
Goltz RW; Coryell GM; Schnieders JR; Neidert GL
Cutis; 1985 Sep; 36(3):265-8. PubMed ID: 2932307
[TBL] [Abstract][Full Text] [Related]
4. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.
Becker LE; Bergstresser PR; Whiting DA; Clendenning WE; Dobson RL; Jordan WP; Abell E; LeZotte LA; Pochi PE; Shupack JL; Sigafoes RB; Stoughton RB; Voorhees JJ
Arch Dermatol; 1981 Aug; 117(8):482-5. PubMed ID: 6455095
[TBL] [Abstract][Full Text] [Related]
5. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
Thomas DR; Raimer S; Smith EB
Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
[TBL] [Abstract][Full Text] [Related]
6. A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris.
Ellis CN; Gammon WR; Stone DZ; Heezen-Wehner JL
Cutis; 1988 Sep; 42(3):245-7. PubMed ID: 2971512
[TBL] [Abstract][Full Text] [Related]
7. Topical clindamycin versus oral tetracycline and placebo in acne vulgaris.
Braathen LR
Scand J Infect Dis Suppl; 1984; 43():71-5. PubMed ID: 6242073
[TBL] [Abstract][Full Text] [Related]
8. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effectiveness of clindamycin phosphate (1% solution) compared with tetracycline (solution) administered topically in the treatment of acne vulgaris].
Bran EL; Robledo Aguilar A
Med Cutan Ibero Lat Am; 1986; 14(6):433-42. PubMed ID: 2951570
[TBL] [Abstract][Full Text] [Related]
10. Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris.
Katsambas A; Towarky AA; Stratigos J
Br J Dermatol; 1987 Mar; 116(3):387-91. PubMed ID: 2952156
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Richter JR; Förström LR; Kiistala UO; Jung EG
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
[TBL] [Abstract][Full Text] [Related]
12. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
13. Clindamycin vs placebo as adjunctive therapy in moderately severe acne.
Christian GL; Krueger GG
Arch Dermatol; 1975 Aug; 111(8):997-1000. PubMed ID: 134670
[TBL] [Abstract][Full Text] [Related]
14. [1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
Schmidt JB; Neumann R; Fanta D; Raab W
Z Hautkr; 1988 May; 63(5):374-6. PubMed ID: 2970159
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS
Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
[TBL] [Abstract][Full Text] [Related]
16. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris.
Charakida A; Charakida M; Chu AC
Br J Dermatol; 2007 Sep; 157(3):569-74. PubMed ID: 17635508
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris.
Stoughton RB; Cornell RC; Gange RW; Walter JF
Cutis; 1980 Oct; 26(4):424-5, 429. PubMed ID: 6448131
[TBL] [Abstract][Full Text] [Related]
19. Topical clindamycin versus systemic tetracycline in the treatment of acne. Results of a multiclinic trial.
Gratton D; Raymond GP; Guertin-Larochelle S; Maddin SW; Leneck CM; Warner J; Collins JP; Gaudreau P; Bendl BJ
J Am Acad Dermatol; 1982 Jul; 7(1):50-3. PubMed ID: 6213682
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study.
Iraji F; Momeni A; Naji SM; Siadat AH
Dermatol Online J; 2006 Mar; 12(3):26. PubMed ID: 16638440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
